Radiofrequency ablation for hepatocellular carcinoma

References

• Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 2004;127:S5–16
   PubMed Web of Science ®Google Scholar
• McGlynn KA, London WT. The global epidemiology of hepatocellular carcinoma: Present and future. Clin Liver Dis 2011;15:223–43
   PubMed Web of Science ®Google Scholar
• Livraghi T, Mäkisalo H, Line PD. Treatment options in hepatocellular carcinoma today. Scand J Surg 2011;100:22–9
   PubMed Web of Science ®Google Scholar
• El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012;142:1264–73
   PubMed Web of Science ®Google Scholar
• de Lope CR, Tremosini S, Forner A, Reig M, Bruix J. Management of HCC. J Hepatol 2012;56:S75–87
   PubMed Web of Science ®Google Scholar
• El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011;365:1118–27
   PubMed Web of Science ®Google Scholar
• Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, et al. Surgery for small liver cancers. Semin Surg Oncol 1993;9:298–304
   PubMedGoogle Scholar
• Zhou WP, Lai EC, Li AJ, Fu SY, Zhou JP, Pan ZY, et al. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surgery 2009;249:195–202
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Arimoto A, Wakasa T, Kita R, Kimura T, Osaki Y. Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma. Int J Oncol 2013;42:151–60
   PubMed Web of Science ®Google Scholar
• Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693–9
   PubMed Web of Science ®Google Scholar
• Takayama T, Makuuchi M, Hasegawa K. Single HCC smaller than 2 cm: Surgery or ablation? Surgeon's perspective. J Hepatobiliary Pancreat Sci 2010;17:422–4
   PubMed Web of Science ®Google Scholar
• Ikai I, Arii S, Kojiro M, Ichida T, Makuuchi M, Matsuyama Y, et al. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer 2004;101:796–802
   PubMed Web of Science ®Google Scholar
• Tanaka S, Noguchi N, Ochiai T, Kudo A, Nakamura N, Ito K, et al. Outcomes and recurrence of initially resectable hepatocellular carcinoma meeting Milan criteria: Rationale for partial hepatectomy as first strategy. J Am Coll Surg 2007;204:1–6
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Osaki Y, Kita R, Kimura T, Inuzuka T, Sakaomoto A, et al. Transcatheter arterial infusion chemotherapy prior to radiofrequency thermal ablation for single hepatocellular carcinoma reduces the risk of intrahepatic distant recurrence. Int J Oncol 2012;41:903–9
   PubMed Web of Science ®Google Scholar
• Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006;131:461–9
   PubMed Web of Science ®Google Scholar
• Seki T, Wakabayashi M, Nakagawa T, Itho T, Shiro T, Kunieda K, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994;74:817–25
   PubMed Web of Science ®Google Scholar
• Hinshaw JL, Lee FT Jr. Cryoablation for liver cancer. Tech Vasc Interv Radiol 2007;10:47–57
   PubMedGoogle Scholar
• Rossi S, Di Stasi M, Buscarini E, Cavanna L, Quaretti P, Squassante E, et al. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. Cancer J Sci Am 1995;1:73–81
   PubMedGoogle Scholar
• Livraghi T, Vettori C. Percutaneous ethanol injection therapy of hepatoma. Cardiovasc Intervent Radiol 1990;13:146–52
   PubMed Web of Science ®Google Scholar
• Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, et al. Small hepatocellular carcinoma in cirrhosis: Randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228:235–40
   PubMed Web of Science ®Google Scholar
• Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology 2004;127:1714–23
   PubMed Web of Science ®Google Scholar
• Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005;54:1151–6
   PubMed Web of Science ®Google Scholar
• Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129:122–30
   PubMed Web of Science ®Google Scholar
• Brunello F, Veltri A, Carucci P, Pagano E, Ciccone G, Moretto P, et al. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial. Scand J Gastroenterol 2008;43:727–35
   PubMed Web of Science ®Google Scholar
• Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006;243:321–8
   PubMed Web of Science ®Google Scholar
• Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 2010;252:903–12
   PubMed Web of Science ®Google Scholar
• Feng K, Yan J, Li X, Xia F, Ma K, Wang S, et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 2012;57:794–802
   PubMed Web of Science ®Google Scholar
• Boucher E, Corbinais S, Brissot P, Boudjema K, Raoul JL. Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen). Cancer Chemother Pharmacol 2002;50:305–8
   PubMed Web of Science ®Google Scholar
• Yeo W, Mok TS, Zee B, Leung TW, Lai PB, Lau WY, et al. A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma. J Natl Cancer Inst 2005;97:1532–8
   PubMed Web of Science ®Google Scholar
• Gish RG, Porta C, Lazar L, Ruff P, Feld R, Croitoru A, et al. Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin. J Clin Oncol 2007;25:3069–75
   PubMed Web of Science ®Google Scholar
• Edeline J, Raoul JL, Vauleon E, Guillygomac’h A, Boudjema K, Boucher E. Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver: A retrospective study. World J Gastroenterol 2009;15:713–6
   PubMed Web of Science ®Google Scholar
• Hiroki Nishikawa, Yukio Osaki, Ryuichi Kita, Toru Kimura. Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in Japan. Cancers 2012;4:165–83
   PubMedGoogle Scholar
• Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378–90
   PubMed Web of Science ®Google Scholar
• Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 2009;10:25–34
   PubMed Web of Science ®Google Scholar
• Kudo M. Current status of molecularly targeted therapy for hepatocellular carcinoma: Clinical practice. Int J Clin Oncol 2010;15:242–55
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Osaki Y, Iguchi E, Takeda H, Nakajima J, Matsuda F, et al. Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinoma. Exp Ther Med 2012;4:381–6
   PubMed Web of Science ®Google Scholar
• Inuzuka T, Nishikawa H, Sekikawa A, Takeda H, Henmi S, Sakamoto A, et al. Complete response of advanced hepatocellular carcinoma with multiple lung metastases treated with sorafenib: A case report. Oncology 2011;81:152–7
   PubMed Web of Science ®Google Scholar
• Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000;232:381–91
   PubMed Web of Science ®Google Scholar
• Kurokohchi K, Masaki T, Himoto T, Deguchi A, Nakai S, Yoneyama H, et al. Successful laparoscopic radiofrequency ablation of hepatocellular carcinoma adhered to the mesentery after transcatheter arterial embolization. Oncol Rep 2005;13:65–8
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Kohno T, Shibayama T, Fukushima Y, Obi S, Teratani T, et al. Thoracoscopic thermal ablation therapy for hepatocellular carcinoma located beneath the diaphragm. Endoscopy 2001;33:697–702
   PubMed Web of Science ®Google Scholar
• Tiong L, Maddern GJ. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2011;98:1210–24
   PubMed Web of Science ®Google Scholar
• Kudo M. Radiofrequency ablation for hepatocellular carcinoma: Updated review in 2010. Oncology 2010;78:113–24
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Inuzuka T, Takeda H, Nakajima J, Matsuda F, Sakamoto A, et al. Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma. BMC Gastroenterol 2011;11:143
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Osaki Y, Iguchi E, Takeda H, Ohara Y, Sakamoto A, et al. Percutaneous radiofrequency ablation therapy for recurrent hepatocellular carcinoma. Anticancer Res 2012;32:5059–65
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Osaki Y, Iguchi E, Takeda H, Ohara Y, Sakamoto A, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma: Clinical outcome and safety in elderly patients. J Gastrointestin Liver Dis 2012;21:397–405
   PubMed Web of Science ®Google Scholar
• Arii S, Sata M, Sakamoto M, Shimada M, Kumada T, Shiina S, et al. Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatol Res 2010;40:667–85
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Kokudo N, Makuuchi S, Izumi N, Ichida T, Kudo M, et al. Comparison of resection and ablation for hepatocellular carcinoma: A cohort study based on a Japanese nationwide survey. J Hepatol 2013;58:724–9
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208–36
   PubMed Web of Science ®Google Scholar
• Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol 2012;107:569–77
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Osaki Y, Iguchi E, Takeda H, Matsuda F, Nakajima J, et al. Radiofrequency ablation for hepatocellular carcinoma: The relationship between a new grading system for the ablative margin and clinical outcomes. J Gastroenterol 2012. doi 10.1007/s00535-012-0690-0
   Google Scholar
• Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002;89:1206–22
   PubMed Web of Science ®Google Scholar
• Ikeda M, Okada S, Ueno H, Okusaka T, Kuriyama H. Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: A comparative study. Jpn J Clin Oncol 2001;31:322–6
   PubMed Web of Science ®Google Scholar
• Germani G, Pleguezuelo M, Gurusamy K, Meyer T, Isgro G, Burroughs AK. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: A meta-analysis. J Hepatol 2010;52:380–8
   PubMed Web of Science ®Google Scholar
• Kudo M. Local ablation therapy for hepatocellular carcinoma: Current status and future perspectives. J Gastroenterol 2004;39:205–14
   PubMed Web of Science ®Google Scholar
• Kasugai H, Osaki Y, Oka H, Kudo M, Seki T; Osaka Liver Cancer Study Group. Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: An analysis of 3,891 ablations in 2,614 patients. Oncology 2007;72:72–5
   PubMed Web of Science ®Google Scholar
• Koda M, Tokunaga S, Miyoshi K, Kishina M, Fujise Y, Kato J, et al. Assessment of ablative margin by enhanced magnetic resonance imaging after radiofrequency ablation for hepatocelluar carcinoma. Eur J Radiol 2012;81:2730–6
   PubMed Web of Science ®Google Scholar
• Tokunaga S, Koda M, Matono T, Sugihara T, Nagahara T, Ueki M, et al. Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer: Comparison with enhanced CT. Br J Radiology 2012;85:745–52
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Inuzuka T, Takeda H, Nakajima J, Sakamoto A, Henmi S, et al. Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: A proposed new grading system for the ablative margin and prediction of local tumor progression and its validation. J Gastroenterol 2011;46:1418–26
   PubMed Web of Science ®Google Scholar
• Koda M, Tokunaga S, Miyoshi K, Kishina M, Fujise Y, Kato J, et al. Ablative margin states by magnetic resonance imaging with ferucarbotran in radiofrequency ablation for hepatocellular carcinoma can predict local tumor progression. J Gastroenterol 2013. doi 10.1007/s00535-012-0747-0
   Google Scholar
• Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: Treatment with radio-frequency ablation versus ethanol injection. Radiology 1999;210:655–61
   PubMed Web of Science ®Google Scholar
• Shiina S, Tagawa K, Unuma T, Takanashi R, Yoshiura K, Komatsu Y, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study. Cancer 1991;68:1524–30
   PubMed Web of Science ®Google Scholar
• Sala M, Llovet JM, Vilana R, Bianchi L, Sole M, Ayuso C, et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004;40:1352–60
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Hahn PF, Tanabe KK, Mueller PR, Schima W, Athanasoulis CA, et al. Percutaneous radiofrequency tissue ablation: Does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 1998;9:101–11
   PubMed Web of Science ®Google Scholar
• Goldberg SN. Radio frequency tumor ablation: Principles and techniques. Eur J Ultrasound 2001;13:129–47
   PubMedGoogle Scholar
• Shibata T, Iimuro Y, Yamamoto Y, Maetani Y, Ametani F, Itoh K, et al. Small hepatocellular carcinoma: Comparison of radiofrequency ablation and percutaneous microwave coagulation therapy. Radiology 2002;223:331–7
   PubMed Web of Science ®Google Scholar
• Lu MD, Xu HX, Xie XY, Yin XY, Chen JW, Kuang M, et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: A retrospective comparative study. J Gastroenterol 2005;40:1054–60
   PubMed Web of Science ®Google Scholar
• Ohmoto K, Yoshioka N, Tomiyama Y, Shibata N, Kawase T, Yoshida K, et al. Radiofrequency ablation versus percutaneous microwave coagulation therapy for small hepatocellular carcinomas: A retrospective comparative study. Hepatogastroenterology 2007;54:985–9
   PubMed Web of Science ®Google Scholar
• Livraghi T, Meloni F, Solbiati L, Zanus G; Collaborative Italian Group using AMICA system. Complications of microwave ablation for liver tumors: Results of a multicenter study. Cardiovasc Intervent Radiol 2012;35:868–74
   PubMed Web of Science ®Google Scholar
• Yu NC, Raman SS, Kim YJ, Lassman C, Chang X, Lu DS. Microwave liver ablation: Influence of hepatic vein size on heat-sink effect in a porcine model. J Vasc Interv Radiol 2008;19:1087–92
   PubMed Web of Science ®Google Scholar
• Liu FY, Yu XL, Liang P, Wang Y, Zhou P, Yu J. Comparison of percutaneous 915 MHz microwave ablation and 2450 MHz microwave ablation in large hepatocellular carcinoma. Int J Hyperthermia 2010;26:448–55
   PubMed Web of Science ®Google Scholar
• Hong SN, Lee SY, Choi MS, Lee JH, Koh KC, Paik SW, et al. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well preserved hepatic function. J Clin Gastroenterol 2005;39:247–52
   PubMed Web of Science ®Google Scholar
• Montorsi M, Santambrogio R, Bianchi P, Donadon M, Moroni E, Spinelli A, et al. Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: A multivariate analysis. J Gastrointest Surg 2005;9:62–7
   PubMed Web of Science ®Google Scholar
• Cho CM, Tak WY, Kweon YO, Kim SK, Choi YH, Hwang YJ, et al. The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma. Korean J Hepatol 2005;11:59–71
   PubMedGoogle Scholar
• Ogihara M, Wong LL, Machi J. Radiofrequency ablation versus surgical resection for single nodule hepatocellular carcinoma: Long-term outcomes. HPB (Oxford) 2005;7:214–21
   PubMedGoogle Scholar
• Lu MD, Kuang M, Liang LJ, Xie XY, Peng BG, Liu GJ, et al. Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: A randomized clinical trial. Zhonghua Yi Xue Za Zhi 2006;86:801–5
   PubMedGoogle Scholar
• Lupo L, Panzera P, Giannelli G, Memeo M, Gentile A, Memeo V. Single hepatocellular carcinoma ranging from 3 to 5 cm: Radiofrequency ablation or resection? HPB (Oxford) 2007;9:429–34
   PubMedGoogle Scholar
• Hasegawa K, Makuuchi M, Takayama T, Kokudo N, Arii S, Okazaki M, et al. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: A preliminary report of the Japanese nationwide survey. J Hepatol 2008;49:589–94
   PubMed Web of Science ®Google Scholar
• Guglielmi A, Ruzzenente A, Valdegamberi A, Pachera S, Campagnaro T, D'Onofrio M, et al. Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 2008;12:192–8
   PubMed Web of Science ®Google Scholar
• Abu-Hilal M, Primrose JN, Casaril A, McPhail MJ, Pearce NW, Nicoli N. Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma. J Gastrointest Surg 2008;12:1521–6
   PubMed Web of Science ®Google Scholar
• Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y, et al. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg 2009;16:359–66
   PubMedGoogle Scholar
• Zhou Y, Zhao Y, Li B, Xu D, Yin Z, Xie F, et al. Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol 2010;10:78
   PubMed Web of Science ®Google Scholar
• Osaki Y, Ueda Y, Marusawa H, Kimura T, Kita R, Nishikawa H, et al. Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: A single center study. J Gastroenterol 2012;47:444–51
   PubMed Web of Science ®Google Scholar
• Shiratori Y, Shiina S, Teratani T, Imamura M, Obi S, Sato S, et al. Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus. Ann Intern Med 2003;138:299–306
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Osaki Y, Iguchi E, Koshikawa Y, Ako S, Inuzuka T, et al. The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation. J Clin Gastroenterol 2013;47:359–66
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Kokudo N, Shiina S, Tateishi R, Makuuchi M. Surgery versus radiofrequency ablation for small hepatocellular carcinoma: Start of a randomized controlled trial (SURF trial). Hepatol Res 2010;40:851–2
   PubMed Web of Science ®Google Scholar
• Yamasaki T, Kimura T, Kurokawa F, Aoyama K, Ishikawa T, Tajima K, et al. Percutaneous radiofrequency ablation with cooled electrodes combined with hepatic arterial balloon occlusion in hepatocellular carcinoma. J Gastroenterol 2005;40:171–8
   PubMed Web of Science ®Google Scholar
• Takaki H, Yamakado K, Uraki J, Nakatsuka A, Fuke H, Yamamoto N, et al. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm. J Vasc Interv Radiol 2009;20:217–24
   PubMed Web of Science ®Google Scholar
• Cheng BQ, Jia CQ, Liu CT, Fan W, Wang QL, Zhang ZL, et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: A randomized controlled trial. JAMA 2008;299:1669–77
   PubMed Web of Science ®Google Scholar
• Morimoto M, Numata K, Kondou M, Nozaki A, Morita S, Tanaka K. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: A randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization. Cancer 2010;116:5452–60
   PubMed Web of Science ®Google Scholar
• Peng ZW, Zhang YJ, Chen MS, Xu L, Liang HH, Lin XJ, et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: A prospective randomized trial. J Clin Oncol 2013;31:426–32
   PubMed Web of Science ®Google Scholar
• Lu Z, Wen F, Guo Q, Liang H, Mao X, Sun H. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: A meta-analysis of randomized-controlled trials. Eur J Gastroenterol Hepatol 2013;25:187–94
   PubMed Web of Science ®Google Scholar
• Shibata T, Isoda H, Hirokawa Y, Arizono S, Shimada K, Togashi K. Small hepatocelluar carcinoma: Is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Radiology 2009;252:905–13
   PubMed Web of Science ®Google Scholar
• de Baere T, Bessoud B, Dromain C, Ducreux M, Boige V, Lassau N, et al. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. Am J Roentgenol 2002;178:53–9
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Osaki Y, Inuzuka T, Takeda H, Nakajima J, Matsuda F, et al. Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2012;18:1379–84
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Liang HH, Chen MS, Guo RP, Li JQ, Zheng Y, et al. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: A prospective randomized trial. Radiology 2007;244:599–607
   PubMed Web of Science ®Google Scholar
• Kurokohchi K, Watanabe S, Masaki T, Hosomi N, Funaki T, Arima K, et al. Combination therapy of percutaneous ethanol injection and radiofrequency ablation against hepatocellular carcinomas difficult to treat. Int J Oncol 2002;21:611–5
   PubMed Web of Science ®Google Scholar
• Lau WY, Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: A systematic review. Ann Surg 2009;249:20–5
   PubMed Web of Science ®Google Scholar
• Lencioni R. Loco-regional treatment of hepatocellular carcinoma. Hepatology 2010;52:762–73
   PubMed Web of Science ®Google Scholar
• Sheiman RG, Mullan C, Ahmed M. In vivo determination of a modified heat capacity of small hepatocellular carcinomas prior to radiofrequency ablation: Correlation with adjacent vasculature and tumour recurrence. Int J Hyperthermia 2012;28:122–31
   PubMed Web of Science ®Google Scholar
• Ogawa T, Kawamoto H, Kobayashi Y, Nakamura S, Miyatake H, Harada R, et al. Prevention of biliary complication in radiofrequency ablation for hepatocellular carcinoma: Cooling effect by endoscopic nasobiliary drainage tube. Eur J Radiol 2010;73:385–90
   PubMed Web of Science ®Google Scholar
• Zhen ZJ, Lau WY, Wang FJ, Lai EC. Laparoscopic liver resection for hepatocellular carcinoma in the left liver: Pringle maneuver versus tourniquet method. World J Surg 2010;34:314–9
   PubMed Web of Science ®Google Scholar
• Kotoh K, Nakamuta M, Morizono S, Kohjima M, Arimura E, Fukushima M, et al. A multi-step, incremental expansion method for radio frequency ablation: Optimization of the procedure to prevent increases in intra-tumor pressure and to reduce the ablation time. Liver Int 2005;25:542–7
   PubMed Web of Science ®Google Scholar
• Giorgio A. Percutaneous radiofrequency ablation of hepatocellular carcinoma on cirrhosis: State of the art and future perspectives. Recent Pat Anticancer Drug Discov 2010;5:69–76
   PubMed Web of Science ®Google Scholar
• Minami Y, Kudo M, Kawasaki T, Chung H, Ogawa C, Inoue T, et al. Percutaneous ultrasound-guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. J Gastroenterol 2003;38:1066–70
   PubMed Web of Science ®Google Scholar
• Minami Y, Kudo M, Kawasaki T, Chung H, Ogawa C, Shiozaki H. Percutaneous radiofrequency ablation guided by contrast-enhanced harmonic sonography with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. Am J Roentgenol 2004;182:1224–6
   PubMed Web of Science ®Google Scholar
• Kondo Y, Yoshida H, Shiina S, Tateishi R, Teratani T, Omata M. Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract. Br J Surg 2006;93:1277–82
   PubMed Web of Science ®Google Scholar
• Song I, Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: Safety and technical efficacy in 143 patients. Eur Radiol 2009;19:2630–40
   PubMed Web of Science ®Google Scholar
• Kitada T, Murakami T, Kuzushita N, Minamitani K, Nakajo K, Osuga K, et al. Effectiveness of real-time virtual sonography-guided radiofrequency ablation treatment for patients with hepatocellular carcinomas. Hepatol Res 2008;38:565–71
   PubMed Web of Science ®Google Scholar
• Minami Y, Chung H, Kudo M, Kitai S, Takahashi S, Inoue T, et al. Radiofrequency ablation of hepatocellular carcinoma: Value of virtual CT sonography with magnetic navigation. Am J Roentgenol 2008;190:W335–41
   PubMed Web of Science ®Google Scholar
• Masuzaki R, Shiina S, Tateishi R, Yoshida H, Goto E, Sugioka Y, et al. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma. J Gastroenterol Hepatol 2011;26:759–4
   PubMedGoogle Scholar
• Kudo M, Hatanaka K, Maekawa K. Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma. Oncology 2010;78:40–5
   PubMed Web of Science ®Google Scholar
• Dohmen T, Kataoka E, Yamada I, Miura K, Ohshima S, Shibuya T, et al. Efficacy of contrast-enhanced ultrasonography in radiofrequency ablation for hepatocellular carcinoma. Intern Med 2012;51:1–7
   PubMed Web of Science ®Google Scholar
• Xu M, Xie XH, Xie XY, Xu ZF, Liu GJ, Zheng YL, et al. Sorafenib suppresses the rapid progress of hepatocellular carcinoma after insufficient radiofrequency ablation therapy: An experiment in vivo. Acta Radiol 2013;54:199–204
   PubMed Web of Science ®Google Scholar
• Poon RT, Borys N. Lyso-thermosensitive liposomal doxorubicin: An adjuvant to increase the cure rate of radiofrequency ablation in liver cancer. Future Oncol 2011;7:937–45
   PubMed Web of Science ®Google Scholar
• Guo Y, Zhang Y, Klein R, Nijm GM, Sahakian AV, Omary RA, et al. Irreversible electroporation therapy in the liver: Longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res 2010;70:1555–63
   PubMed Web of Science ®Google Scholar
• Cheung W, Kavnoudias H, Roberts S, Szkandera B, Kemp W, Thomson KR. Irreversible electroporation for unresectable hepatocellular carcinoma: Initial experience and review of safety and outcomes. Technol Cancer Res Treat 2013;12:233–41
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, et al. Advanced hepatocellular carcinoma: Treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology 2005;235:659–67
   PubMed Web of Science ®Google Scholar
• Ng KK, Poon RT, Chan SC, Chok KS, Cheung TT, Tung H, et al. High-intensity focused ultrasound for hepatocellular carcinoma: A single-center experience. Ann Surg 2011;253:981–7
   PubMed Web of Science ®Google Scholar
• Lu YC, Chen YJ, Yu YR, Lai YH, Cheng JC, Li YF, et al. Replicating retroviral vectors for oncolytic virotherapy of experimental hepatocellular carcinoma. Oncol Rep 2012;28:21–6
   PubMed Web of Science ®Google Scholar
• Cheon YK, Cho YD, Moon JH, Jang JY, Kim YS, Kim YS, et al. Diagnostic utility of interleukin-6 (IL-6) for primary bile duct cancer and changes in serum IL-6 levels following photodynamic therapy. Am J Gastroenterol 2007;102:2164–70
   PubMed Web of Science ®Google Scholar
• Patriciu A, Awad M, Solomon SB, Choti M, Mazilu D, Kavoussi L, et al. Robotic assisted radio-frequency ablation of liver tumors: Randomized patient study. Med Image Comput Comput Assist Interv 2005;8:526–33
   PubMedGoogle Scholar
• Poggi G, Montagna B, DI Cesare P, Riva G, Bernardo G, Mazzucco M, et al. Microwave ablation of hepatocellular carcinoma using a new percutaneous device: Preliminary results. Anticancer Res 2013;33:1221–7
   PubMed Web of Science ®Google Scholar
• Lee SM, Won JY, Lee DY, Lee KH, Lee KS, Paik YH, et al. Percutaneous cryoablation of small hepatocellular carcinomas using a 17-gauge ultrathin probe. Clin Radiol 2011;66:752–9
   PubMed Web of Science ®Google Scholar
• Francica G, Petrolati A, Di Stasio E, Pacella S, Stasi R, Pacella CM. Effectiveness, safety, and local progression after percutaneous laser ablation for hepatocellular carcinoma nodules up to 4 cm are not affected by tumor location. Am J Roentgenol 2012;199:1393–401
   PubMed Web of Science ®Google Scholar